期刊文献+

胶质瘤中PKCα表达及与细胞增殖和凋亡的关系 被引量:3

Relation of PKCα,cellular proliferation and apoptosis in gliomas
下载PDF
导出
摘要 目的 探讨人脑胶质瘤中PKCα的表达情况 ,以及与细胞增殖和凋亡的关系。方法  37例人脑胶质瘤标本 ,星形细胞瘤 2 5例和胶质母细胞瘤 12例 ,正常脑组织 10例作为对照。PKCα和Ki 6 7的检测用免疫组化 ,细胞凋亡用TUNEL。用Ki 6 7LI和AI对增殖和凋亡进行评估。结果 PKCα在胶质瘤及正常组织中均有表达 ,前者为 6 7.6 % ,后者为 30 .0 % ,二者有显著性差异 ,星形细胞瘤阳性率为 6 0 % ,胶质母细胞瘤为 83.3% ,不同肿瘤分型中PKCα表达有差异 ,PKCα表达与细胞增殖和生长显著相关 ,与凋亡无明显相关。结论 人脑胶质瘤中PKCα过度表达 。 Objective To study the alteration of protein kinase Cα(PKCα) in gliomas, analyze the relationship with cellular proliferation and apoptosis.Methods Thirty seven gliomas were classed by WHO standard (1990) as astrocytomas (25 cases, including fibrillary, 7 cases; protoplasmic, 6 cases; anaplastic, 12 cases), glioblastomas (12 cases, including GBM, 4 cases). Ten normal brain tissues were taken as control. The expression of PKCα and cell proliferation marker, Ki 67 were detected by immunohistochemical method. Cellar apoptosis was detected by TUNEL. Cellar proliferation and apoptosis were assessed by Ki 67 label index (Ki 67 LI) and apoptotic indices (AI). Results PKCα was expressed in gliomas as well as normal brain tissues. The former was 67.6% (25/37), while the later was 30.0% (3/10), there was significant difference between them ( P =0.04). The positive rate was 60% (15/25) in astrocytomas , and 83.3% (10/12) in glioblastomas, it was different among tumor types ( P =0.018). PKCα expression was associated with Ki 67 LI and cell overall daily growth (KP), but was not with apoptotic indices (AI).Conclusion PKCα was overexpressed in gliomas, and related with tumorigenesis and pathogenesis closely, which was basic theory to treating gliomas with PKC inhibitors.
出处 《中华神经外科疾病研究杂志》 CAS 2004年第1期16-19,共4页 Chinese Journal of Neurosurgical Disease Research
基金 江苏省科委社会发展科技计划资助项目 (BS2 0 0 0 0 57)
关键词 PKCΑ 细胞增殖 细胞凋亡 脑胶质瘤 蛋白激酶C Gliomas Protein kinase Cα Proliferation Apoptosis
  • 相关文献

参考文献2

二级参考文献15

  • 1王忠诚,张俊廷,杨少华,刘阿力,孙波,罗麟.脊髓髓内肿瘤的手术治疗[J].中华神经外科杂志,1997,13(3):128-134. 被引量:122
  • 2[1]Kordek R, Bratosiewicz J, Biemat W, et al. Expression of p53-pro-tein, epidermal growth factor receptor(EGFR) and proliferating cellantigens in human gliomas. Folia Neuropathol, 1994, 32: 4227-4228.
  • 3[2]Hsu DW, Louis DN, Efird JT, et al. Use of MIB-1 (Ki-67) im-munoreactivity in differentiating grade Ⅱ1 and grade Ⅲ gliomas. JNeuropathol Exp Neurol, 1997, 56: 8857-8865.
  • 4[3]Nakamura M, Konishi N, Tsunoda S, et al. Retinoblastoma proteinexpression and MIB-1 correlate with survival of patients with malig-nant astrocytoma. Cancer, 1997, 80:242-249.
  • 5[4]Schiffer D, Cavalla P, Migheli A. Apoptosis and cell proliferation inhuman neuroepithelial tumors. Neurosci Lett, 1995, 195:281-284.
  • 6[5]Tews DS. Cell death and oxidative stress in gliomas. NeuropatholAppl Neurobiol, 1999, 25 : 4272-4284.
  • 7Guidette B, Mercuri S, Vagnozzi R. Long-term results of the surgical treatment of 129 intramedullary spinal glioma [J]. J Neurosurg, 1981, 54: 323-330.
  • 8Cooper PR. Management of intramedullary spinal cord tumors [A]. In: Tindall GE. Cooper PR, Barrow DL(eds). The practice of Neurosurgery [M]. Vol 1. Baltimore: Williams & Wilkins, 1996: 1335-1346.
  • 9Hejaze N, Hassler W. Microsurgical treatment of intramedullary spinal cord tumors [J]. Neurol Med. Chir (Tokyo) 1998, 38: 266-273.
  • 10McCormick PC, Torres R, Post KD, et al. Intramedullary spinal cord tumors in adults: Intermediate and long-term results in 51 patients [J]. J Neurosurg, 1990, 75: 523-532.

共引文献36

同被引文献20

  • 1Valtonen S, Timonen U, Toivanen P, et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study [J]. Neurosurgery, 1997, 41(1): 44-49.
  • 2Kevin C, Tadashi K, Yasuko K, et al. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest ,modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy [J]. J Neurosurg, 2003, 98(2): 378-384.
  • 3Tribius S, Pidel A, Casper D, et al. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture [J]. Int J Radiation Oncology Biol Phys, 2001, 50(2): 511-523.
  • 4司徒镇强 吴军正.细胞培养 [M].西安:世界图书出版公司,2004.239-245.
  • 5Mottolese M, Natali PG, Coli A, et al. Comparative analysis of proliferating cell nuclear antigen and epidermal growth factor receptor expression in glial tumors: correlation with histological grading [J]. Anti cancer Res, 1998, 18(3B): 1951-1956.
  • 6Kelman Z. PCNA : structure, functions and interactions [J]. Oncogene, 1997, 14(6): 629-640.
  • 7Palazzo JP, Kafka NJ, Grasso L, et al. The role of p53, p21WAF1/CIPI, and bcl-2 in radioresistant colorectal carcinoma [J]. Hum Pathol, 1997, 28(10): 1189-1195.
  • 8Bjork-Eriksson T, West CM, Cvetskovska E, et al. The lack of correlation between proliferation(Ki 67, PCNA,LI,Tpot), p53 expression and radiosensitivity for head and neck cancers [J]. Br J Cancer, 1999, 80(9): 1400-1404.
  • 9da Rocha AB,Mans DR,Regner A,et al.Targeting protein kinase C:new therapeutic opportunities against high-grade malignant gliomas?[J].Oncologist,2002,7(1):17-33.
  • 10Heiden T,Castanos-Velez E,Andersson LC,et al.Combined analysis of DNA ploidy,proliferation,and apoptosis in paraffin-embedded cell material by flow cytometry[J].Lab Invest,2000,80 (8):1207-1213.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部